[Successful use of levosimendan in a patient with cardiogenic shock complicating acute myocardial infarction]
Tunisie Medicale [La]. 2005; 83 (10): 635-637
in French
| IMEMR
| ID: emr-75270
ABSTRACT
Levosimendan is a new inodilator that improves cardiac contractility by sensitizing troponin C to calcium. This drug has proved to be effective in treating advanced congestive heart failure but has not been evaluated in cardiogenic shock. We present the case of a 54-year-old male patient treated successfully with levosimendan for cardiogenic shock following acute myocardial infarction. Treatment with dobulamine, revascularisation and intra-aortic balloon conterpulsation had first failed to improve his hemodynamic variables. Levosimendan induced a steady decline of increased pulmonary capillary wedge pressure, followed by an increase in cardiac index and mixed venous oxygen saturation. Left ventricular ejection fraction improved from 25% to 47%. Infusion of levosimendan can be used in cardiogenic shock without side effects and to improve hemodynamics and left ventricular function
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Echocardiography
/
Cardiotonic Agents
/
Catecholamines
/
Heterotrophic Processes
/
Myocardial Infarction
Type of study:
Case report
Limits:
Humans
/
Male
Language:
French
Journal:
Tunisie Med.
Year:
2005
Similar
MEDLINE
...
LILACS
LIS